Ralliant (NYSE:RAL) Issues FY 2026 Earnings Guidance

Key Points

• Ralliant raised or updated its FY 2026 outlook to EPS of $2.76–$2.90 and revenue of approximately $2.3 billion, exceeding analysts’ consensus estimates of $2.65 EPS and $2.2 billion in revenue. Q3 2026 EPS guidance was set at $0.72–$0.78.
• The company’s latest quarterly results beat expectations, with EPS of $0.68 versus the $0.63 consensus estimate on revenue of $567.8 million. Analysts maintain a “Moderate Buy” consensus rating with a $73 average price target, despite one recent downgrade to “Hold.”
• RAL shares opened down 1.3% at $66.85, while Ralliant continues to pay a quarterly dividend of $0.05 per share, equivalent to a $0.20 annualized payout and a 0.3% yield.

Ralliant (NYSE:RAL - Get Free Report) updated its FY 2026 earnings guidance on Thursday morning. The company provided EPS guidance of 2.760-2.900 for the period, compared to the consensus EPS estimate of 2.650. The company issued revenue guidance of $2.3 billion-$2.3 billion, compared to the consensus revenue estimate of $2.2 billion. Ralliant also updated its Q3 2026 guidance to 0.720-0.780 EPS.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the stock. Wall Street Zen downgraded shares of Ralliant from a "buy" rating to a "hold" rating in a research note on Sunday. BMO Capital Markets assumed coverage on shares of Ralliant in a research report on Monday, July 20th. They set a "market perform" rating and a $78.00 price target on the stock. Truist Financial reissued a "buy" rating and issued a $68.00 price target (up from $53.00) on shares of Ralliant in a report on Wednesday, May 13th. Citigroup upped their price objective on shares of Ralliant from $70.00 to $81.00 and gave the company a "buy" rating in a research report on Monday, July 13th. Finally, Morgan Stanley raised their price objective on Ralliant from $68.00 to $85.00 and gave the stock an "overweight" rating in a research note on Tuesday, June 23rd. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, Ralliant has a consensus rating of "Moderate Buy" and a consensus price target of $73.00.

Ralliant Stock Down 1.3%

RAL stock opened at $66.85 on Thursday. The company has a market cap of $7.48 billion and a price-to-earnings ratio of -6.11. Ralliant has a twelve month low of $37.27 and a twelve month high of $75.41. The business has a 50 day moving average price of $66.98 and a two-hundred day moving average price of $54.16. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 0.73.

Ralliant (NYSE:RAL - Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported $0.68 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.63 by $0.05. The company had revenue of $567.80 million for the quarter. Ralliant had a positive return on equity of 12.49% and a negative net margin of 58.55%.Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. Analysts anticipate that Ralliant will post 2.64 EPS for the current fiscal year.

Ralliant Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 8th were issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date was Monday, June 8th. Ralliant's payout ratio is presently -1.83%.

Institutional Trading of Ralliant

A number of large investors have recently added to or reduced their stakes in RAL. Palisade Asset Management LLC bought a new stake in shares of Ralliant in the 3rd quarter valued at about $26,000. BOKF NA bought a new position in Ralliant during the third quarter worth about $29,000. Wilmington Savings Fund Society FSB acquired a new position in Ralliant during the third quarter worth approximately $30,000. EverSource Wealth Advisors LLC acquired a new position in Ralliant during the second quarter worth approximately $39,000. Finally, NewEdge Advisors LLC bought a new stake in Ralliant in the second quarter valued at approximately $43,000.

About Ralliant

Ralliant, Inc NYSE: RAL is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient's own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company's core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.